SCHEMBL24672063

SCHEMBL24672063

CCCCCCCCc1ccc(-c2ccc(CO)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 6/20 0.64
ALDH1A1 P00352 2/20 0.64
RARA P10276 2/20 0.64
MEN1 O00255 1/20 0.64
MAPT P10636 1/20 0.64
MTOR P42345 1/20 0.64
KMT2A Q03164 1/20 0.64
ESR1 P03372 2/20 0.62
ADRA2A P08913 2/20 0.62
ADORA3 P0DMS8 2/20 0.62
TACR2 P21452 2/20 0.62
SLC6A2 P23975 2/20 0.62
SLC6A4 P31645 2/20 0.62
SLC6A3 Q01959 2/20 0.62
HSD17B10 Q99714 2/20 0.62
KDM4E B2RXH2 1/20 0.62
LMNA P02545 1/20 0.62
SHBG P04278 1/20 0.62
TP53 P04637 1/20 0.62
CYP3A4 P08684 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8543684 1.00 RARB (0.64) RARBALDH1A1RARAMEN1MAPT
SCHEMBL9808819 1.00 RARB (0.64) RARBALDH1A1RARAMEN1MAPT
SCHEMBL11282877 1.00 RARB (0.64) RARBALDH1A1RARAMEN1MAPT
SCHEMBL10985836 0.98 RARB (0.62) RARBALDH1A1RARAMEN1MAPT
SCHEMBL9600021 0.94 ESR1 (0.69) RARBALDH1A1ESR1ADRA2AADORA3
SCHEMBL359311 0.94 ESR1 (0.69) RARBALDH1A1ESR1ADRA2AADORA3
SCHEMBL11031408 0.94 ESR1 (0.69) RARBALDH1A1ESR1ADRA2AADORA3
SCHEMBL176980 0.94 ESR1 (0.69) RARBALDH1A1ESR1ADRA2AADORA3
SCHEMBL4297552 0.94 ESR1 (0.69) RARBALDH1A1ESR1ADRA2AADORA3
SCHEMBL7769065 0.94 ESR1 (0.69) RARBALDH1A1ESR1ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220296579-A1 COMPOSITIONS AND METHODS FOR PROVIDING CARDIOPROTECTIVE EFFECTS CORNELL UNIVERSITY (US) 2022-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220296579-A1 COMPOSITIONS AND METHODS FOR PROVIDING CARDIOPROTECTIVE EFFECTS RARB, RARG, RARA RARB 1/4885ALDH1A1 214/4885RARA 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.